×
About 2,845 results

ALLMedicine™ Gangrene Center

Research & Reviews  965 results

Favorable Outcomes with Early Component Separation, Primary Closure of Necrotizing Soft...
https://doi.org/10.1016/j.urology.2022.03.042
Urology Sandberg JM, Warner HL et. al.

May 19th, 2022 - To evaluate the efficacy of early necrotizing soft-tissue infections of the genitalia (NSTIG) component separation, primary wound closure (CSC). We hypothesized that early CSC would be safe, decrease the need for split-thickness skin grafting (STS...

Study of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease
https://clinicaltrials.gov/ct2/show/NCT04912323

May 16th, 2022 - The prevalence of peripheral artery disease (PAD) is estimated to be over 200 million. Critical limb ischemia (CLI) is considered the most advanced stage of PAD, occurring in about 10% of PAD patients. CLI patients typically present with ischemic ...

Treatment of MDA5-positive dermatomyositis complicated by gangrenous cholecystitis with...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107581
European Journal of Medical Research; Luo M, Chen L et. al.

May 16th, 2022 - Dermatomyositis is a rare idiopathic inflammatory disease with diverse presentations that can have varying degrees of cutaneous and systemic involvement. This phenotypic heterogeneity makes DM a therapeutic challenge. Some therapeutic drugs, such ...

Scleroderma and Raynaud Phenomenon: The Cold Truth Regarding the Use of Operative Manag...
https://doi.org/10.1097/PRS.0000000000009187
Plastic and Reconstructive Surgery; Hakami LM, Forster GL et. al.

May 12th, 2022 - Raynaud phenomenon, with and without scleroderma, is a common vasospastic condition that manifests with extremity pain and skin discoloration. When conservative management fails, complications such as ischemia, ulceration, and gangrene may warrant...

Digital gangrene in a woman with scleroderma.
https://doi.org/10.1503/cmaj.212106
CMAJ : Canadian Medical Association Journal = Journal De ... Chatterjee S

May 10th, 2022 - Digital gangrene in a woman with scleroderma.|2022|Chatterjee S,|etiology,complications,

see more →

Guidelines  1 results

Global vascular guidelines on the management of chronic limb-threatening ischemia.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365864
Journal of Vascular Surgery; Conte MS, Bradbury AW et. al.

Jun 5th, 2019 - Chronic limb-threatening ischemia (CLTI) is associated with mortality, amputation, and impaired quality of life. These Global Vascular Guidelines (GVG) are focused on definition, evaluation, and management of CLTI with the goals of improving evide...

see more →

Drugs  11 results see all →

Clinicaltrials.gov  33 results

Study of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease
https://clinicaltrials.gov/ct2/show/NCT04912323

May 16th, 2022 - The prevalence of peripheral artery disease (PAD) is estimated to be over 200 million. Critical limb ischemia (CLI) is considered the most advanced stage of PAD, occurring in about 10% of PAD patients. CLI patients typically present with ischemic ...

Management of the Diabetic Foot Using Electrolysed Water
https://clinicaltrials.gov/ct2/show/NCT02841969

Apr 22nd, 2022 - Study design: The entrance criteria specify adult diabetic patients (18-65 years) with chronic (>6 weeks) non-healing wounds(>2cm2) identified by study clinicians and counselled by aid of a Participant Information sheet (PIS). Having considered th...

Proteomics and Stem Cell Therapy as a New Vascularization Strategy
https://clinicaltrials.gov/ct2/show/NCT02802852

Nov 15th, 2021 - Twenty-five CLI patients with ischemic forefoot rest pain, non-healing forefoot ulceration, or dry forefoot gangrene will be recruited. They will have already undergone standard of care evaluation, including hemodynamic testing and duplex ultrasou...

Effectiveness of the Autologous Adipose Tissue Harvested With SEFFICARE Method for Treatment of DFU Minor Amputation
https://clinicaltrials.gov/ct2/show/NCT05072353

Oct 8th, 2021 - Diabetic foot ulcers (DFU) are one of the complications of diabetes mellitus resulting from multiple causes such as neuropathy, ischemia, and infection that contribute to morbidity and amputation. The prevalence of DFU has been estimated to be 3 t...

Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes
https://clinicaltrials.gov/ct2/show/NCT01600924

Sep 29th, 2021 - Impaired muscle strength has been reported in subjects with type 1 and type 2 diabetes as a late complication of severe diabetic peripheral neuropathy (DPN). However, reduction of muscle strength has been shown to occur earlier in the course of di...

see more →

News  121 results

Diabetes-Related Amputations Kept at Bay During Pandemic in Canada
https://www.medpagetoday.com/primarycare/diabetes/96511

Jan 5th, 2022 - Despite delays in screening and care during the COVID-19 pandemic, there wasn't a spike in diabetes-related foot amputations, a Canadian study found. In an analysis of nearly 1.5 million adults with diabetes living in Ontario, rates for nearly all...

SPECIAL REPORT-J&J kept quiet on popular diabetes drug as red flags multiplied
https://www.reuters.com/article/usa-diabetes-invokana/special-report-jj-kept-quiet-on-popular-diabetes-drug-as-red-flags-multiplied-idUSL1N2SO1N0

Dec 8th, 2021 - (For more Reuters Special Reports, click on) RARITAN, New Jersey, Dec 8 (Reuters) - Gathered for an emergency meeting, the Johnson & Johnson drug safety team painted an alarming scene: People taking the company’s new blockbuster diabetes drug were...

Cell Therapy Promising as Long-Term, Limb-Saving Treatment in Diabetes
https://www.medscape.com/viewarticle/960265

Oct 5th, 2021 - Bone marrow derived autologous cell therapy (ACT) has been shown to significantly reduce the rate of major amputation at 5 years in people with diabetes who developed critical limb-threatening ischemia (CLTI). In a study of 130 patients, 64% of 42...

Delta Variant and COVID-19 Vaccines: What to Know
https://www.medscape.com/viewarticle/952897

Jun 10th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. As the highly transmissible Delta coronavirus variant continues to devastate India and spread to other nations, health experts are reiterating the...

Farxiga Gets FDA Greenlight for CKD
https://www.medpagetoday.com/nephrology/generalnephrology/92372

Apr 30th, 2021 - FDA expanded the indication for dapagliflozin (Farxiga) into chronic kidney disease (CKD). The drug, which first entered the market for type 2 diabetes in 2014, was approved to reduce the risk of kidney function decline, kidney failure, cardiovasc...

see more →

Patient Education  7 results see all →